CN Stock MarketDetailed Quotes

600223 Lushang Freda Pharmaceutical

Watchlist
  • 8.21
  • -0.49-5.63%
Market Closed May 23 15:00 CST
8.35BMarket Cap35.85P/E (TTM)

Lushang Freda Pharmaceutical Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

All
YOY yoy
Hide blank lines yoy
(Q3)Mar 31, 2024
(FY)Dec 31, 2023
(Q9)Sep 30, 2023
(Q6)Jun 30, 2023
(Q3)Mar 31, 2023
(FY)Dec 31, 2022
(Q9)Sep 30, 2022
(Q6)Jun 30, 2022
(Q3)Mar 31, 2022
(FY)Dec 31, 2021
Total operating revenue
-29.99%890.64M
-64.65%4.58B
-60.20%3.39B
-48.85%2.47B
-14.17%1.27B
4.76%12.95B
34.33%8.53B
18.88%4.84B
-13.08%1.48B
-9.20%12.36B
Operating revenue
-29.99%890.64M
-64.65%4.58B
-60.20%3.39B
-48.85%2.47B
-14.17%1.27B
4.76%12.95B
34.33%8.53B
18.88%4.84B
-13.08%1.48B
-9.20%12.36B
Other operating revenue
----
-76.90%67.66M
----
-58.54%38.11M
----
80.96%292.87M
----
63.65%91.91M
----
-15.74%161.85M
Total operating cost
-32.38%833.25M
-64.92%4.37B
-61.03%3.21B
-48.81%2.35B
-12.12%1.23B
7.14%12.45B
43.21%8.23B
23.72%4.59B
-11.00%1.4B
-10.05%11.62B
Operating cost
-43.21%437.84M
-74.89%2.45B
-71.50%1.8B
-58.67%1.38B
-11.75%771.02M
6.23%9.76B
46.23%6.3B
19.28%3.34B
-23.94%873.64M
-15.30%9.19B
Operating tax surcharges
801.60%9.36M
-93.25%36.42M
-94.41%24.17M
-94.69%13.32M
-101.69%-1.33M
-8.32%539.39M
44.54%432.44M
32.47%250.91M
-22.90%78.81M
-21.34%588.31M
Operating expense
0.97%322.98M
10.12%1.45B
12.26%1.09B
7.76%718.67M
7.86%319.86M
4.79%1.31B
20.57%968.99M
35.95%666.93M
39.89%296.54M
47.67%1.25B
Administration expense
-38.10%36.82M
-36.29%222.98M
-30.39%157.25M
-22.75%108.91M
-20.99%59.47M
-7.87%349.98M
-9.57%225.88M
-20.05%140.99M
-12.16%75.27M
15.74%379.88M
Financial expense
-112.44%-6.63M
-83.81%57.07M
-81.34%40.51M
-53.59%63.2M
-4.12%53.3M
287.97%352.54M
19,856.64%217.05M
4,985.90%136.2M
1,342.81%55.59M
34.18%90.87M
-Interest expense (Financial expense)
-91.22%5.02M
-76.37%94.75M
-73.23%68.03M
-42.44%81.82M
-21.24%57.16M
257.00%400.97M
811.14%254.08M
861.25%142.16M
750.62%72.57M
23.15%112.32M
-Interest Income (Financial expense)
-55.20%-11.88M
5.18%-44.95M
8.40%-30.27M
10.76%-21.1M
56.48%-7.65M
-24.00%-47.4M
-24.66%-33.04M
-29.65%-23.64M
-128.08%-17.59M
-5.45%-38.23M
Research and development
10.09%32.89M
14.52%153.36M
27.11%100.47M
17.94%64.77M
33.72%29.88M
12.77%133.92M
-1.63%79.04M
8.04%54.92M
-3.96%22.34M
53.89%118.75M
Credit Impairment Loss
-366.63%-1.91M
55.69%-29.63M
-90.94%-29.55M
-61.91%-28.07M
-217.42%-409.71K
33.83%-66.86M
66.15%-15.48M
65.05%-17.34M
97.14%-129.07K
-43.08%-101.05M
Asset Impairment Loss
----
94.07%-15.92M
-162.76%-573.33K
-162.42%-570.17K
----
-37.22%-268.33M
175.63%913.48K
412.23%913.48K
----
-4,252.91%-195.56M
Other net revenue
-82.94%22.85M
207.86%207.21M
79.91%162.06M
168.89%149.53M
496.84%133.94M
-186.18%-192.12M
27.27%90.08M
29.54%55.61M
65.33%22.44M
-137.98%-67.13M
Invest income
-88.50%14.66M
84.45%214.34M
109.37%175.58M
184.36%166.59M
778.25%127.44M
-42.28%116.21M
-16.20%83.86M
-29.60%58.59M
2.13%14.51M
-8.30%201.34M
-Including: Investment income associates
44.80%14.54M
-34.85%72M
-38.46%48.23M
-26.10%39.25M
11.17%10.04M
-44.96%110.51M
-21.64%78.37M
-36.15%53.11M
-36.25%9.04M
-5.32%200.79M
Asset deal income
3,486.04%526.18K
-200.61%-773.78K
-137.26%-258.99K
-98.48%10.59K
-67.84%14.67K
1,815.99%769.05K
1,668.57%695K
1,668.57%695K
45.35%45.62K
-149.27%-44.82K
Other revenue
38.75%9.57M
50.17%39.19M
-16.03%16.87M
-9.29%11.57M
-13.92%6.9M
-7.40%26.1M
24.51%20.09M
32.09%12.75M
108.40%8.02M
-12.62%28.18M
Operating profit
-53.87%80.24M
34.94%419.45M
-10.54%350.26M
-9.01%273.05M
69.76%173.93M
-54.13%310.85M
-41.98%391.55M
-24.93%300.09M
-28.50%102.46M
-22.59%677.67M
Add:Non operating Income
-10.88%301.73K
-60.13%2.24M
-78.11%1.04M
-74.28%675.59K
-76.87%338.58K
22.61%5.62M
64.00%4.74M
67.33%2.63M
33.83%1.46M
4.30%4.58M
Less:Non operating expense
-97.58%183.5K
-84.25%8.73M
-80.62%7.96M
-26.54%7.81M
158.56%7.57M
43.82%55.41M
16.16%41.06M
49.25%10.63M
289.59%2.93M
46.52%38.53M
Total profit
-51.80%80.35M
58.19%412.96M
-3.35%343.34M
-8.96%265.91M
65.06%166.69M
-59.45%261.06M
-44.70%355.23M
-25.90%292.08M
-29.69%100.99M
-24.58%643.73M
Less:Income tax cost
-42.15%7.31M
-76.11%46.82M
-75.43%41.62M
-63.46%31.43M
-63.46%12.64M
-21.60%195.96M
16.14%169.38M
9.87%86.01M
-32.04%34.59M
16.46%249.93M
Net profit
-52.59%73.04M
462.44%366.14M
62.35%301.72M
13.79%234.48M
132.00%154.05M
-83.47%65.1M
-62.57%185.85M
-34.77%206.07M
-28.40%66.4M
-38.36%393.8M
Net profit from continuing operation
-52.59%73.04M
287.97%252.56M
62.35%301.72M
13.79%234.48M
132.00%154.05M
-83.47%65.1M
-62.57%185.85M
-34.77%206.07M
-28.40%66.4M
-38.36%393.8M
Net income from discontinuing operating
----
--113.58M
----
----
----
----
----
----
----
----
Less:Minority Profit
-43.35%14.01M
219.47%62.75M
98.58%63.69M
161.15%44.06M
22,723.38%24.72M
-38.42%19.64M
586.95%32.07M
249.96%16.87M
-98.44%108.32K
14,380.88%31.9M
Net profit of parent company owners
-54.35%59.04M
567.44%303.39M
54.79%238.03M
0.65%190.42M
95.09%129.33M
-87.44%45.46M
-69.44%153.77M
-39.18%189.2M
-22.74%66.3M
-43.34%361.9M
Earning per share
Basic earning per share
-53.85%0.06
650.00%0.3
53.33%0.23
0.00%0.19
85.71%0.13
-88.89%0.04
-70.00%0.15
-38.71%0.19
-17.65%0.07
-43.75%0.36
Diluted earning per share
-53.85%0.06
650.00%0.3
53.33%0.23
0.00%0.19
116.67%0.13
-88.57%0.04
-69.39%0.15
-36.67%0.19
-29.41%0.06
-44.44%0.35
Other composite income
Total composite income
-52.59%73.04M
462.44%366.14M
62.35%301.72M
13.79%234.48M
132.00%154.05M
-83.47%65.1M
-62.57%185.85M
-34.77%206.07M
-28.40%66.4M
-38.36%393.8M
Total composite income of parent company owners
-54.35%59.04M
567.44%303.39M
54.79%238.03M
0.65%190.42M
95.09%129.33M
-87.44%45.46M
-69.44%153.77M
-39.18%189.2M
-22.74%66.3M
-43.34%361.9M
Total composite income of minority owners
-43.35%14.01M
219.47%62.75M
98.58%63.69M
161.15%44.06M
22,723.38%24.72M
-38.42%19.64M
586.95%32.07M
249.96%16.87M
-98.44%108.32K
14,380.88%31.9M
Currency Unit
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
Accounting Standards
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
Audit Opinions
--
Unqualified opinion
--
--
--
Unqualified opinion
--
--
--
Unqualified opinion
Auditor
--
Shanghui Certified Public Accountants (Special General Partnership)
--
--
--
Shanghui Certified Public Accountants (Special General Partnership)
--
--
--
Daishin Certified Public Accountants (Special General Partnership)
(Q3)Mar 31, 2024(FY)Dec 31, 2023(Q9)Sep 30, 2023(Q6)Jun 30, 2023(Q3)Mar 31, 2023(FY)Dec 31, 2022(Q9)Sep 30, 2022(Q6)Jun 30, 2022(Q3)Mar 31, 2022(FY)Dec 31, 2021
Total operating revenue -29.99%890.64M-64.65%4.58B-60.20%3.39B-48.85%2.47B-14.17%1.27B4.76%12.95B34.33%8.53B18.88%4.84B-13.08%1.48B-9.20%12.36B
Operating revenue -29.99%890.64M-64.65%4.58B-60.20%3.39B-48.85%2.47B-14.17%1.27B4.76%12.95B34.33%8.53B18.88%4.84B-13.08%1.48B-9.20%12.36B
Other operating revenue -----76.90%67.66M-----58.54%38.11M----80.96%292.87M----63.65%91.91M-----15.74%161.85M
Total operating cost -32.38%833.25M-64.92%4.37B-61.03%3.21B-48.81%2.35B-12.12%1.23B7.14%12.45B43.21%8.23B23.72%4.59B-11.00%1.4B-10.05%11.62B
Operating cost -43.21%437.84M-74.89%2.45B-71.50%1.8B-58.67%1.38B-11.75%771.02M6.23%9.76B46.23%6.3B19.28%3.34B-23.94%873.64M-15.30%9.19B
Operating tax surcharges 801.60%9.36M-93.25%36.42M-94.41%24.17M-94.69%13.32M-101.69%-1.33M-8.32%539.39M44.54%432.44M32.47%250.91M-22.90%78.81M-21.34%588.31M
Operating expense 0.97%322.98M10.12%1.45B12.26%1.09B7.76%718.67M7.86%319.86M4.79%1.31B20.57%968.99M35.95%666.93M39.89%296.54M47.67%1.25B
Administration expense -38.10%36.82M-36.29%222.98M-30.39%157.25M-22.75%108.91M-20.99%59.47M-7.87%349.98M-9.57%225.88M-20.05%140.99M-12.16%75.27M15.74%379.88M
Financial expense -112.44%-6.63M-83.81%57.07M-81.34%40.51M-53.59%63.2M-4.12%53.3M287.97%352.54M19,856.64%217.05M4,985.90%136.2M1,342.81%55.59M34.18%90.87M
-Interest expense (Financial expense) -91.22%5.02M-76.37%94.75M-73.23%68.03M-42.44%81.82M-21.24%57.16M257.00%400.97M811.14%254.08M861.25%142.16M750.62%72.57M23.15%112.32M
-Interest Income (Financial expense) -55.20%-11.88M5.18%-44.95M8.40%-30.27M10.76%-21.1M56.48%-7.65M-24.00%-47.4M-24.66%-33.04M-29.65%-23.64M-128.08%-17.59M-5.45%-38.23M
Research and development 10.09%32.89M14.52%153.36M27.11%100.47M17.94%64.77M33.72%29.88M12.77%133.92M-1.63%79.04M8.04%54.92M-3.96%22.34M53.89%118.75M
Credit Impairment Loss -366.63%-1.91M55.69%-29.63M-90.94%-29.55M-61.91%-28.07M-217.42%-409.71K33.83%-66.86M66.15%-15.48M65.05%-17.34M97.14%-129.07K-43.08%-101.05M
Asset Impairment Loss ----94.07%-15.92M-162.76%-573.33K-162.42%-570.17K-----37.22%-268.33M175.63%913.48K412.23%913.48K-----4,252.91%-195.56M
Other net revenue -82.94%22.85M207.86%207.21M79.91%162.06M168.89%149.53M496.84%133.94M-186.18%-192.12M27.27%90.08M29.54%55.61M65.33%22.44M-137.98%-67.13M
Invest income -88.50%14.66M84.45%214.34M109.37%175.58M184.36%166.59M778.25%127.44M-42.28%116.21M-16.20%83.86M-29.60%58.59M2.13%14.51M-8.30%201.34M
-Including: Investment income associates 44.80%14.54M-34.85%72M-38.46%48.23M-26.10%39.25M11.17%10.04M-44.96%110.51M-21.64%78.37M-36.15%53.11M-36.25%9.04M-5.32%200.79M
Asset deal income 3,486.04%526.18K-200.61%-773.78K-137.26%-258.99K-98.48%10.59K-67.84%14.67K1,815.99%769.05K1,668.57%695K1,668.57%695K45.35%45.62K-149.27%-44.82K
Other revenue 38.75%9.57M50.17%39.19M-16.03%16.87M-9.29%11.57M-13.92%6.9M-7.40%26.1M24.51%20.09M32.09%12.75M108.40%8.02M-12.62%28.18M
Operating profit -53.87%80.24M34.94%419.45M-10.54%350.26M-9.01%273.05M69.76%173.93M-54.13%310.85M-41.98%391.55M-24.93%300.09M-28.50%102.46M-22.59%677.67M
Add:Non operating Income -10.88%301.73K-60.13%2.24M-78.11%1.04M-74.28%675.59K-76.87%338.58K22.61%5.62M64.00%4.74M67.33%2.63M33.83%1.46M4.30%4.58M
Less:Non operating expense -97.58%183.5K-84.25%8.73M-80.62%7.96M-26.54%7.81M158.56%7.57M43.82%55.41M16.16%41.06M49.25%10.63M289.59%2.93M46.52%38.53M
Total profit -51.80%80.35M58.19%412.96M-3.35%343.34M-8.96%265.91M65.06%166.69M-59.45%261.06M-44.70%355.23M-25.90%292.08M-29.69%100.99M-24.58%643.73M
Less:Income tax cost -42.15%7.31M-76.11%46.82M-75.43%41.62M-63.46%31.43M-63.46%12.64M-21.60%195.96M16.14%169.38M9.87%86.01M-32.04%34.59M16.46%249.93M
Net profit -52.59%73.04M462.44%366.14M62.35%301.72M13.79%234.48M132.00%154.05M-83.47%65.1M-62.57%185.85M-34.77%206.07M-28.40%66.4M-38.36%393.8M
Net profit from continuing operation -52.59%73.04M287.97%252.56M62.35%301.72M13.79%234.48M132.00%154.05M-83.47%65.1M-62.57%185.85M-34.77%206.07M-28.40%66.4M-38.36%393.8M
Net income from discontinuing operating ------113.58M--------------------------------
Less:Minority Profit -43.35%14.01M219.47%62.75M98.58%63.69M161.15%44.06M22,723.38%24.72M-38.42%19.64M586.95%32.07M249.96%16.87M-98.44%108.32K14,380.88%31.9M
Net profit of parent company owners -54.35%59.04M567.44%303.39M54.79%238.03M0.65%190.42M95.09%129.33M-87.44%45.46M-69.44%153.77M-39.18%189.2M-22.74%66.3M-43.34%361.9M
Earning per share
Basic earning per share -53.85%0.06650.00%0.353.33%0.230.00%0.1985.71%0.13-88.89%0.04-70.00%0.15-38.71%0.19-17.65%0.07-43.75%0.36
Diluted earning per share -53.85%0.06650.00%0.353.33%0.230.00%0.19116.67%0.13-88.57%0.04-69.39%0.15-36.67%0.19-29.41%0.06-44.44%0.35
Other composite income
Total composite income -52.59%73.04M462.44%366.14M62.35%301.72M13.79%234.48M132.00%154.05M-83.47%65.1M-62.57%185.85M-34.77%206.07M-28.40%66.4M-38.36%393.8M
Total composite income of parent company owners -54.35%59.04M567.44%303.39M54.79%238.03M0.65%190.42M95.09%129.33M-87.44%45.46M-69.44%153.77M-39.18%189.2M-22.74%66.3M-43.34%361.9M
Total composite income of minority owners -43.35%14.01M219.47%62.75M98.58%63.69M161.15%44.06M22,723.38%24.72M-38.42%19.64M586.95%32.07M249.96%16.87M-98.44%108.32K14,380.88%31.9M
Currency Unit CNYCNYCNYCNYCNYCNYCNYCNYCNYCNY
Accounting Standards CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)
Audit Opinions --Unqualified opinion------Unqualified opinion------Unqualified opinion
Auditor --Shanghui Certified Public Accountants (Special General Partnership)------Shanghui Certified Public Accountants (Special General Partnership)------Daishin Certified Public Accountants (Special General Partnership)

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
CN
Overall
Symbol
Latest Price
%Chg